miR-135a-5p alleviates morphine tolerance by targeting the regulation of CXCL12 expression

doi:10.16352/j.issn.1001-6325.2024.05.0665

Abstract

Abstract: Objective Investigating the effect of miR-135a-5p in regulating of CXCL12 on the formation of morphine tolerance in C57BL/6J mice. Methods Totally 64 mice were randomly divided into the following groups: control (NS) group, morphine tolerance (MT) group, CXCL12 inhibitor (CXCL12-siRNA) group, inhibitor negative control (NC-siRNA) group, miR-135a-5p agonist (miR-agomir) group, agonist negative control (miR-NC) group, miR-135a-5p agonist+CXCL12 overexpression (miR-agomir+LV-CXCL12) group, and miR-135a-5p agonist+CXCL12 over-expression negative control (miR-agomir+LV-control) group. Morphine tolerance models were established by subcutaneous injection. The tail-flick test was used to measure the thermal tail-flick latency (TL) before and after drug administration in each group. After modeling, the mice were euthanized under anesthesia, and L4~L5 spinal cord tissues were collected. RT-qPCR method was used to detect the expression of miR-135a-5p and CXCL12 mRNA, Western blot was used to detect the expression of CXCL12 proteins, and a dual luciferase reporter gene assay was used to detect the targeting relationship between miR-135a-5p and CXCL12. Results 1)The morphine-tolerant mouse model demonstrated a significant increase in CXCL12 mRNA and protein expression(P＜0.05) and a significant downregulation of miR-135a-5p (P＜0.05) compared to the NS group. 2)Silencing Cxcl12 and over-expression of miR-135a-5p both increased the thermal pain threshold in morphine-tolerant mice, significantly slowed down the occurrence and progression of morphine tolerance. 3)Compared to the miR-NC group, the miR-agomir group showed a decrease in both CXCL12 mRNA and protein expression(P＜0.05). 4)Dual-luciferase reporter gene experiments demonstrated that miR-135a-5p was targeted at Cxcl12. 5)Over-expression of CXCL12 reversed the thermal pain-protective effect of miR-135a-5p in morphine-tolerant mice. Conclusions It is demonstrated by the results above that miR-135a-5p alleviates the formation of morphine tolerance by suppressing the expression of CXCL12.

Key words: morphine tolerance, C-X-C motif chemokine ligand 12(CXCL12), microRNA, miR-135a-5p

CLC Number:

R441.1
R614

HE Huamei, LU Wei. miR-135a-5p alleviates morphine tolerance by targeting the regulation of CXCL12 expression[J]. Basic & Clinical Medicine, 2024, 44(5): 665-672.

References

[1] Deng G. Integrative medicine therapies for pain management in cancer patients[J]. Cancer J, 2019,25:343-348.
[2] Schaefer CP, Tome ME, Davis TP. The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse[J]. Fluids Barriers CNS, 2017,14:32. doi:10.1186/s12987-017-0080-3.
[3] Bai X, Huang Y, Zhang K, et al. CircNf1-mediated CXCL12 expression in the spinal cord contributes to morphine anal-gesic tolerance[J]. Brain Behav Immun, 2023,107:140-151.
[4] Chen X, Geller EB, Rogers TJ, et al. Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats[J]. Drug Alcohol Depend, 2007,88: 36-41.
[5] Zhang TJ, Qiu Y, Hua Z. The emerging perspective of morphine tolerance: microRNAs[J]. Pain Res Manag, 2019,2019:9432965. doi:10.1155/2019/9432965.
[6] Guo XY, Liu QL, Liu W, et al. Effect and mechanism of miR-135a-5p/CXCL12/JAK-STAT axis on inflammatory response after myocardial infarction[J]. Eur Rev Med Pharmacol Sci, 2020,24: 12912-12928.
[7] Wan L, Jia RM, Ji LL, et al. AMPK-autophagy-mediated inhibition of microRNA-30a-5p alleviates morphine tolerance via SOCS3-dependent neuroinflammation suppression[J]. J Neuroinflammation, 2022,19: 25. doi:10.1186/s12974-022-02384-3.
[8] 唐淑洁, 张佳琦, 刘洋, 等. 洛芬待因与吗啡交替服用减少吗啡在癌痛患者中的耐药性[J]. 中国医学创新, 2016,6: 29-31.
[9] Paul AK, Smith CM, Rahmatullah M, et al. Opioid analgesia and opioid-induced adverse effects: a review[J]. Pharmaceuticals (Basel), 2021,14:1091. doi:10.3390/ph14111091.
[10] Hill R, Canals M. Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology[J]. Pharmacol Ther, 2022,230:107961. doi:10.1016/j.pharmthera.2021.107961.
[11] Zhou J, Ma R, Jin Y, et al. Molecular mechanisms of opioid tolerance: from opioid receptors to inflammatory mediators (Review)[J]. Exp Ther Med, 2021,22:1004. doi:10.3892/etm.2021.10437.
[12] Choi E, Lee H, Park HS, et al. Effect of intraoperative infusion of ketamine on remifentanil-induced hyperalgesia[J]. Korean J Anesthesiol, 2015, 68: 476-480.
[13] Matsushita Y, Ueda H. Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation[J]. Neuroreport, 2009,20: 63-68.
[14] Inan S, Chen X, Eisenstein EM, et al. Chemokine receptor antagonists enhance morphine′s antinociceptive effect but not respiratory depression[J]. Life Sci, 2021,285: 120014. doi:10.1016/j.lfs.2021.120014.
[15] Liu M, Cheng X, Yan H, et al. miR-135-5p alleviates bone cancer pain by regulating astrocyte-mediated neuroinflammation in spinal cord through JAK2/STAT3 signaling pathway[J]. Mol Neurobiol, 2021,58: 4802-4815.